Skip to main content

Table 3 Comparison between the non-insulin group before and after treatment (n = 22)

From: Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

Parameter Before After
BMI (kg/m2) n = 19 23.2 ± 1.0 23.3 ± 1.0
Systolic blood pressure (mmHg) n = 20 155.7 ± 6.3 162.3 ± 5.4
Diastolic blood pressure (mmHg) n = 20 78.7 ± 3.3 79.7 ± 3.0
Total protein (g/dL) 6.5 ± 0.1 6.6 ± 0.1
Albumin (g/dL) 3.7 ± 0.1 3.8 ± 0.1
AST (U/L) 14.9 ± 1.0 13.4 ± 1.2
ALT (U/L) n = 21 11.6 ± 1.4 10.1 ± 1.6
γ1.6 (U/L) 22.3 ± 3.0 23.2 ± 3.4
Total bilirubin (mg/dL) n = 17 0.35 ± 0.03 0.28 ± 0.02*
ALP (U/L) n = 21 251.0 ± 28.4 256.7 ± 25.8
LDH (U/L) n = 21 189.5 ± 6.0 179.2 ± 6.1
BUN (mg/dL) 54.5 ± 1.8 53.8 ± 2.3
Creatinine (mg/dL) 8.21 ± 0.34 8.28 ± 0.44
Total cholesterol (mg/dL) 162.6 ± 8.2 149.6 ± 6.9*
LDL-C (mg/dL) n = 21 83.1 ± 5.9 75.8 ± 5.0*
HDL-C (mg/dL) 46.9 ± 3.4 47.5 ± 3.5
Triglyceride (mg/dL) n = 21 119.7 ± 9.4 121.2 ± 11.9
CPR (ng/mL) n = 19 10.62 ± 1.20 11.56 ± 1.32
BG (mg/dL) 163.7 ± 9.2 162.7 ± 8.1
GA (%) 22.0 ± 0.8 21.2 ± 0.8
BNP (ng/mL) n = 21 429.2 ± 98.5 360.0 ± 79.3
hsCRP (mg/dL) n = 20 0.178 ± 0.046 0.193 ± 0.073
8OHdG (ng/mL) n = 12 0.356 ± 0.022 0.355 ± 0.041
  1. * P < 0.05 compared with before treatment
  2. Abbreviations are the same as shown for Table 2